Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2023 | — | Cantor Fitzgerald | Downgrades | Overweight → Neutral | |
| 11/15/2023 | 785.35% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 08/22/2023 | 342.67% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
| 08/11/2023 | 785.35% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 05/12/2023 | 785.35% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 03/06/2023 | 785.35% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
| 02/22/2023 | 1228.02% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 01/10/2023 | 1228.02% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 09/08/2022 | 564.01% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 1228.02% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 05/26/2021 | 1670.69% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/16/2023 | — | 坎託·菲茨傑拉德 | 降級 | 超重 → 中性 | |
| 11/15/2023 | 785.35% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
| 08/22/2023 | 342.67% | 坎託·菲茨傑拉德 | → 1 美元 | 重申 | 超重 → 超重 |
| 08/11/2023 | 785.35% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
| 05/12/2023 | 785.35% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
| 03/06/2023 | 785.35% | HC Wainwright & Co. | 3 美元 → 2 美元 | 維護 | 買 |
| 02/22/2023 | 1228.02% | HC Wainwright & Co. | → 3 美元 | 重申 | → 購買 |
| 01/10/2023 | 1228.02% | HC Wainwright & Co. | → 3 美元 | 重申 | → 購買 |
| 09/08/2022 | 564.01% | 坎託·菲茨傑拉德 | → 1.5 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 08/10/2022 | 1228.02% | HC Wainwright & Co. | 4 美元 → 3 美元 | 維護 | 買 |
| 2021 年 5 月 26 日 | 1670.69% | HC Wainwright & Co. | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Asensus Surgical (ASXC)?
Asensus Surgical (ASXC) 的目標價格是多少？
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on November 16, 2023. The analyst firm set a price target for $0.00 expecting ASXC to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年11月16日公佈了Asensus Surgical（美國證券交易所股票代碼：ASXC）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計澳大利亞證券交易所將在12個月內跌至12個月內（可能下跌-100.00％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Asensus Surgical (ASXC)?
分析師對Asensus Surgical（ASXC）的最新評級是多少？
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical downgraded their neutral rating.
坎託·菲茨傑拉德對Asensus Surgical（美國證券交易所股票代碼：ASXC）的最新分析師評級由坎託·菲茨傑拉德提供，Asensus Surgical下調了中性評級。
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Asensus Surgical（ASXC）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Asensus Surgical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Asensus Surgical的最新評級是在2023年11月16日發佈的，因此您應該預計下一個評級將在2024年11月16日左右公佈。
Is the Analyst Rating Asensus Surgical (ASXC) correct?
分析師對Asensus Surgical (ASXC) 的評級是否正確？
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a downgraded with a price target of $0.00 to $0.00. The current price Asensus Surgical (ASXC) is trading at is $0.23, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Asensus Surgical（ASXC）評級已下調，目標股價爲0.00美元至0.00美元。Asensus Surgical（ASXC）目前的交易價格爲0.23美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。